The global Gene Therapy market size in 2023 is 7000.0 million US dollars, and it is expected to be 33378.6 million US dollars by 2030, with a compound annual growth rate of 25.0% expected in 2024-2030.

MARKET COMPETITIVE LANDSCAPE:
The main players in the Gene Therapy market include Novartis AG, Biogen, Gilead Science, Inc., Spark Therapeutics, Inc., and Amgen, Inc.. The share of the top 3 players in the Gene Therapy market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Gene Therapy market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. Antigen accounted for XX% of Gene Therapy market in 2023. Receptor share of XX%.
Oncology accounted for XX% of the Gene Therapy market in 2023. Infectious Disease accounts for XX%.

This Gene Therapy market report provides detailed information on latest developments, trade regulations, value chain optimization, market share, impact of domestic and local market players, analyzes emerging revenue sources, market regulation changes Opportunities in Aspects, Strategic Market Growth Analysis, Market Size, Category Market Growth, Application Areas and Dominance, Product Approvals, Product Launches, Geographic Expansion, Technological Innovations in the Market.

Gene Therapy market country level analysis
The countries covered in the Gene Therapy market report include the United States, Canada, Germany, United Kingdom, France, Russia, Japan, China, India, South Korea, Brazil, UAE, Saudi Arabia, etc.
The presence and availability of global brands and challenges due to intense or scarce competition from local and domestic brands, and trade routes are also considered while providing the predictive analysis of country data.

Competitive Landscape and Gene Therapy Market Share Analysis
Gene Therapy market competitive landscape provides details by competitors. The detailed information includes company profile, company financials, revenue generated, market potential, R&D investments, new market plans, global reach. The data points presented above relate only to companies relevant to the Gene Therapy market.

Chapter Outline
Chapter 1: Introduces the product overview, market scope, economic analysis of global regions, and industry dynamic analysis, and then includes inflation analysis, the impact of the Russo-Ukrainian war on the market, and the global impact of the coronavirus disease (COVID-19).
Chapter 2: Analyzes the main companies in the Gene Therapy industry, including their main businesses, products/services, revenue, gross margin, and SWOT Analysis.
Chapter 3: Analysis of the competitive environment of Gene Therapy market participants. This mainly includes the revenue and market share of the top players, along with the players” M&A and new entrants and expansion plans.
Chapters 4-6: Segmented the global Gene Therapy market by type, application and region. Analyze the revenue of market segments from different perspectives.
Chapters 7-11: Provide North America, Europe, Asia-Pacific, Latin America and Middle East & Africa Gene Therapy market type, application, country and player market segmentation data, and include SWOT Analysis.
Chapter 12: Analyzes the Gene Therapy business cost, including industrial chain and the proportion of business cost structure.
Chapter 13: The main points and conclusions of the report.
Chapter 14: Concludes with an explanation of the data sources and research methods.

Highlights-Regions

North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Nordic
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
South America
Brazil
Argentina
MEA
Saudi Arabia
Egypt
Turkey
UAE
South Africa

Player list
Novartis AG
Biogen
Gilead Science, Inc.
Spark Therapeutics, Inc.
Amgen, Inc.
Jazz Pharmaceuticals, Inc.
GlaxoSmithKline plc.
Spartea Therapeutics
Sibiono Gene Tech Co, Ltd.
Orchard Therapeutics
Bluebird Bio, Inc.
Sunway Biotech CO, Ltd.

Types list
Antigen
Receptor
Growth Factors

Application list
Oncology
Infectious Disease
Cardiology

Table of Content

1 Market Overview
1.1 Gene Therapy Introduction
1.2 Market Analysis by Types
1.3 Market Analysis by Applications
1.4 Global Gene Therapy Market Size & Forecast
1.4.1 Global Gene Therapy Revenue (2019 VS 2023 VS 2030)
1.4.2 Global Gene Therapy Revenue in Value (2019-2030)
1.5 Market Drivers, Restraints and Trends
1.5.1 Gene Therapy Market Drivers
1.5.2 Gene Therapy Market Restraints
1.5.3 Gene Therapy Trends Analysis
1.6 Economic Analysis of Global Regions
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
1.9 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Manufacturers Profiles
2.1 Novartis AG
2.1.1 Business Overview
2.1.2 Novartis AG SWOT Analysis
2.1.3 Novartis AG Gene Therapy Products and Service Offered
2.1.4 Novartis AG Gene Therapy Revenue and Gross Margin
2.2 Biogen
2.2.1 Business Overview
2.2.2 Biogen SWOT Analysis
2.2.3 Biogen Gene Therapy Products and Service Offered
2.2.4 Biogen Gene Therapy Revenue and Gross Margin
2.3 Gilead Science, Inc.
2.3.1 Business Overview
2.3.2 Gilead Science, Inc. SWOT Analysis
2.3.3 Gilead Science, Inc. Gene Therapy Products and Service Offered
2.3.4 Gilead Science, Inc. Gene Therapy Revenue and Gross Margin
2.4 Spark Therapeutics, Inc.
2.4.1 Business Overview
2.4.2 Spark Therapeutics, Inc. SWOT Analysis
2.4.3 Spark Therapeutics, Inc. Gene Therapy Products and Service Offered
2.4.4 Spark Therapeutics, Inc. Gene Therapy Revenue and Gross Margin
2.5 Amgen, Inc.
2.5.1 Business Overview
2.5.2 Amgen, Inc. SWOT Analysis
2.5.3 Amgen, Inc. Gene Therapy Products and Service Offered
2.5.4 Amgen, Inc. Gene Therapy Revenue and Gross Margin
2.6 Jazz Pharmaceuticals, Inc.
2.6.1 Business Overview
2.6.2 Jazz Pharmaceuticals, Inc. SWOT Analysis
2.6.3 Jazz Pharmaceuticals, Inc. Gene Therapy Products and Service Offered
2.6.4 Jazz Pharmaceuticals, Inc. Gene Therapy Revenue and Gross Margin
2.7 GlaxoSmithKline plc.
2.7.1 Business Overview
2.7.2 GlaxoSmithKline plc. SWOT Analysis
2.7.3 GlaxoSmithKline plc. Gene Therapy Products and Service Offered
2.7.4 GlaxoSmithKline plc. Gene Therapy Revenue and Gross Margin
2.8 Spartea Therapeutics
2.8.1 Business Overview
2.8.2 Spartea Therapeutics SWOT Analysis
2.8.3 Spartea Therapeutics Gene Therapy Products and Service Offered
2.8.4 Spartea Therapeutics Gene Therapy Revenue and Gross Margin
2.9 Sibiono Gene Tech Co, Ltd.
2.9.1 Business Overview
2.9.2 Sibiono Gene Tech Co, Ltd. SWOT Analysis
2.9.3 Sibiono Gene Tech Co, Ltd. Gene Therapy Products and Service Offered
2.9.4 Sibiono Gene Tech Co, Ltd. Gene Therapy Revenue and Gross Margin
2.10 Orchard Therapeutics
2.10.1 Business Overview
2.10.2 Orchard Therapeutics SWOT Analysis
2.10.3 Orchard Therapeutics Gene Therapy Products and Service Offered
2.10.4 Orchard Therapeutics Gene Therapy Revenue and Gross Margin
2.11 Bluebird Bio, Inc.
2.11.1 Business Overview
2.11.2 Bluebird Bio, Inc. SWOT Analysis
2.11.3 Bluebird Bio, Inc. Gene Therapy Products and Service Offered
2.11.4 Bluebird Bio, Inc. Gene Therapy Revenue and Gross Margin
2.12 Sunway Biotech CO, Ltd.
2.12.1 Business Overview
2.12.2 Sunway Biotech CO, Ltd. SWOT Analysis
2.12.3 Sunway Biotech CO, Ltd. Gene Therapy Products and Service Offered
2.12.4 Sunway Biotech CO, Ltd. Gene Therapy Revenue and Gross Margin
3 Global Gene Therapy Market Competition, by Manufacturer
3.1 Global Gene Therapy Revenue and Market Share by Manufacturer
3.2 Market Concentration Rate
3.2.1 Top 3 Gene Therapy Players Market Share in 2023
3.2.2 Top 6 Gene Therapy Players Market Share in 2023
3.2.3 Market Competition Trend
3.3 Gene Therapy Players Head Office, Business Provided
3.4 Gene Therapy Mergers & Acquisitions
3.5 Gene Therapy New Entrants and Expansion Plans
4 Market Segment by Type
4.1 Global Gene Therapy Revenue in Value by Type (2019-2030)
4.2 Global Gene Therapy Revenue Share by Type (2019-2030)
5 Market Segment by Application
5.1 Global Gene Therapy Revenue by Application (2019-2030)
5.2 Global Gene Therapy Revenue Share by Application (2019-2030)
6 Global Gene Therapy Market Analysis by Regions
6.1 Global Gene Therapy Revenue and Market Share by Regions
6.1.1 Global Gene Therapy Revenue by Regions (2019-2030)
6.1.2 Global Gene Therapy Revenue Market Share by Regions (2019-2030)
6.2 North America Gene Therapy Revenue and Growth (2019-2030)
6.3 Europe Gene Therapy Revenue and Growth (2019-2030)
6.4 Asia Pacific Gene Therapy Revenue and Growth (2019-2030)
6.5 South America Gene Therapy Revenue and Growth (2019-2030)
6.6 Middle East and Africa Gene Therapy Revenue and Growth (2019-2030)
7 North America Gene Therapy by Country, by Type, and by Application
7.1 North America Gene Therapy Revenue by Type (2019-2030)
7.2 North America Gene Therapy Revenue by Application (2019-2030)
7.3 North America Gene Therapy Revenue and Market Share by Countries
7.3.1 North America Gene Therapy Revenue in Value by Country (2019-2030)
7.3.2 United States Gene Therapy Revenue and Growth (2019-2030)
7.3.3 Canada Gene Therapy Revenue and Growth (2019-2030)
7.3.4 Mexico Gene Therapy Revenue and Growth (2019-2030)
7.4 North America SWOT Analysis
8 Europe Gene Therapy by Country, by Type, and by Application
8.1 Europe Gene Therapy Revenue by Type (2019-2030)
8.2 Europe Gene Therapy Revenue by Application (2019-2030)
8.3 Europe Gene Therapy Revenue and Market Share by Countries
8.3.1 Europe Gene Therapy Revenue in Value by Country (2019-2030)
8.3.2 Germany Gene Therapy Revenue and Growth (2019-2030)
8.3.3 France Gene Therapy Revenue and Growth (2019-2030)
8.3.4 United Kingdom Gene Therapy Revenue and Growth (2019-2030)
8.3.5 Russia Gene Therapy Revenue and Growth (2019-2030)
8.3.6 Italy Gene Therapy Revenue and Growth (2019-2030)
8.3.7 Nordic Gene Therapy Revenue and Growth (2019-2030)
8.4 Europe SWOT Analysis
9 Asia Pacific Gene Therapy by Country, by Type, and by Application
9.1 Asia Pacific Gene Therapy Revenue by Type (2019-2030)
9.2 Asia Pacific Gene Therapy Revenue by Application (2019-2030)
9.3 Asia Pacific Gene Therapy Revenue and Market Share by Countries
9.3.1 Asia Pacific Gene Therapy Revenue in Value by Country (2019-2030)
9.3.2 China Gene Therapy Revenue and Growth (2019-2030)
9.3.3 Japan Gene Therapy Revenue and Growth (2019-2030)
9.3.4 Korea Gene Therapy Revenue and Growth (2019-2030)
9.3.5 India Gene Therapy Revenue and Growth (2019-2030)
9.3.6 Southeast Asia Gene Therapy Revenue and Growth (2019-2030)
9.3.7 Australia Gene Therapy Revenue and Growth (2019-2030)
9.4 Asia Pacific SWOT Analysis
10 South America Gene Therapy by Country, by Type, and by Application
10.1 South America Gene Therapy Revenue by Type (2019-2030)
10.2 South America Gene Therapy Revenue by Application (2019-2030)
10.3 South America Gene Therapy Revenue and Market Share by Countries
10.3.1 South America Gene Therapy Revenue in Value by Country (2019-2030)
10.3.2 Brazil Gene Therapy Revenue and Growth (2019-2030)
10.3.3 Argentina Gene Therapy Revenue and Growth (2019-2030)
10.4 South America SWOT Analysis
11 Middle East & Africa Gene Therapy by Country, by Type, and by Application
11.1 Middle East & Africa Gene Therapy Revenue by Type (2019-2030)
11.2 Middle East & Africa Gene Therapy Revenue by Application (2019-2030)
11.3 Middle East & Africa Gene Therapy Revenue and Market Share by Countries
11.3.1 Middle East & Africa Gene Therapy Revenue in Value by Country (2019-2030)
11.3.2 Turkey Gene Therapy Revenue and Growth (2019-2030)
11.3.3 Egypt Gene Therapy Revenue and Growth (2019-2030)
11.3.4 Saudi Arabia Gene Therapy Revenue and Growth (2019-2030)
11.3.5 UAE Gene Therapy Revenue and Growth (2019-2030)
11.3.6 South Africa Gene Therapy Revenue and Growth (2019-2030)
11.4 Middle East and Africa SWOT Analysis
12 Gene Therapy Business Cost Analysis
12.1 Proportion of Business Cost Structure
12.1.1 Labor Cost
12.1.2 Operating Expenses
12.2 Gene Therapy Industrial Chain Analysis
13 Research Findings and Conclusion
14 Methodology and Data Source
14.1 A Methodology
14.1.1 Research Process
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 B Data Source
14.2.1 Legal Disclaimer

List of Tables and Figures

Figure Gene Therapy Picture
Table Product Specifications of Gene Therapy
Figure Global Revenue Market Share of Gene Therapy by Types in 2023
Table Types of Gene Therapy
Figure Gene Therapy Market Share by Applications in 2023
Table Application of Gene Therapy
Figure Global Gene Therapy Revenue (2019 VS 2023 VS 2030)
Figure Global Gene Therapy Revenue in Value (2019-2030)
Table Economic Analysis of Global Regions
Table Inflation Analysis
Table The Impact of the Russian-Ukrainian War on the Market
Figure 2020 (COVID-19) Impact on Global Economic Growth 2019, 2020, 2021
Figure Population infected by the Covid-19 of Major Countries
Table Novartis AG Details
Table SWOT Analysis
Table Novartis AG Gene Therapy Revenue and Gross Margin (2019-2024)
Figure Novartis AG Revenue Market Share 2019-2024
Table Biogen Details
Table SWOT Analysis
Table Biogen Gene Therapy Revenue and Gross Margin (2019-2024)
Figure Biogen Revenue Market Share 2019-2024
Table Gilead Science, Inc. Details
Table SWOT Analysis
Table Gilead Science, Inc. Gene Therapy Revenue and Gross Margin (2019-2024)
Figure Gilead Science, Inc. Revenue Market Share 2019-2024
Table Spark Therapeutics, Inc. Details
Table SWOT Analysis
Table Spark Therapeutics, Inc. Gene Therapy Revenue and Gross Margin (2019-2024)
Figure Spark Therapeutics, Inc. Revenue Market Share 2019-2024
Table Amgen, Inc. Details
Table SWOT Analysis
Table Amgen, Inc. Gene Therapy Revenue and Gross Margin (2019-2024)
Figure Amgen, Inc. Revenue Market Share 2019-2024
Table Jazz Pharmaceuticals, Inc. Details
Table SWOT Analysis
Table Jazz Pharmaceuticals, Inc. Gene Therapy Revenue and Gross Margin (2019-2024)
Figure Jazz Pharmaceuticals, Inc. Revenue Market Share 2019-2024
Table GlaxoSmithKline plc. Details
Table SWOT Analysis
Table GlaxoSmithKline plc. Gene Therapy Revenue and Gross Margin (2019-2024)
Figure GlaxoSmithKline plc. Revenue Market Share 2019-2024
Table Spartea Therapeutics Details
Table SWOT Analysis
Table Spartea Therapeutics Gene Therapy Revenue and Gross Margin (2019-2024)
Figure Spartea Therapeutics Revenue Market Share 2019-2024
Table Sibiono Gene Tech Co, Ltd. Details
Table SWOT Analysis
Table Sibiono Gene Tech Co, Ltd. Gene Therapy Revenue and Gross Margin (2019-2024)
Figure Sibiono Gene Tech Co, Ltd. Revenue Market Share 2019-2024
Table Orchard Therapeutics Details
Table SWOT Analysis
Table Orchard Therapeutics Gene Therapy Revenue and Gross Margin (2019-2024)
Figure Orchard Therapeutics Revenue Market Share 2019-2024
Table Bluebird Bio, Inc. Details
Table SWOT Analysis
Table Bluebird Bio, Inc. Gene Therapy Revenue and Gross Margin (2019-2024)
Figure Bluebird Bio, Inc. Revenue Market Share 2019-2024
Table Sunway Biotech CO, Ltd. Details
Table SWOT Analysis
Table Sunway Biotech CO, Ltd. Gene Therapy Revenue and Gross Margin (2019-2024)
Figure Sunway Biotech CO, Ltd. Revenue Market Share 2019-2024
Table Global Gene Therapy Revenue by Manufacturer (2019-2024)
Figure Global Gene Therapy Revenue Market Share by Manufacturer in 2023
Figure Global Top 3 Companies Revenue Share in 2023
Figure Global Top 6 Companies Revenue Share in 2023
Table Global Gene Therapy Manufacturers Market Concentration Ratio (CR5) (2019-2024)
Table Gene Therapy Players Head Office, Business Provided
Table Mergers & Acquisitions
Table New Entrants and Expansion Plans
Table Global Gene Therapy Revenue in Value by Type (2019-2030)
Table Global Gene Therapy Revenue Share by Type (2019-2030)
Table Global Gene Therapy Revenue by Application (2019-2030)
Table Global Gene Therapy Revenue Share by Application (2019-2030)
Figure Global Gene Therapy Revenue and Growth (2019-2030)
Table Global Gene Therapy Revenue by Regions (2019-2030)
Table Global Gene Therapy Revenue Market Share by Regions (2019-2030)
Figure North America Gene Therapy Revenue and Growth (2019-2030)
Figure Europe Gene Therapy Revenue and Growth (2019-2030)
Figure Asia Pacific Gene Therapy Revenue and Growth (2019-2030)
Figure South America Gene Therapy Revenue and Growth (2019-2030)
Figure Middle East and Africa Gene Therapy Revenue and Growth (2019-2030)
Table North America Gene Therapy Revenue by Type (2019-2030)
Table North America Gene Therapy Revenue by Application (2019-2030)
Table North America Gene Therapy Revenue by Countries (2019-2030)
Table North America Gene Therapy Revenue Market Share by Countries (2019-2030)
Figure United States Gene Therapy Revenue and Growth (2019-2030)
Figure Canada Gene Therapy Revenue and Growth (2019-2030)
Figure Mexico Gene Therapy Revenue and Growth (2019-2030)
Table SWOT Analysis
Table Europe Gene Therapy Revenue by Type (2019-2030)
Table Europe Gene Therapy Revenue by Application (2019-2030)
Table Europe Gene Therapy Revenue by Countries (2019-2030)
Table Europe Gene Therapy Revenue Market Share by Countries (2019-2030)
Figure Germany Gene Therapy Revenue and Growth (2019-2030)
Figure France Gene Therapy Revenue and Growth (2019-2030)
Figure United Kingdom Gene Therapy Revenue and Growth (2019-2030)
Figure Russia Gene Therapy Revenue and Growth (2019-2030)
Figure Italy Gene Therapy Revenue and Growth (2019-2030)
Figure Nordic Gene Therapy Revenue and Growth (2019-2030)
Table SWOT Analysis
Table Asia Pacific Gene Therapy Revenue by Type (2019-2030)
Table Asia Pacific Gene Therapy Revenue by Application (2019-2030)
Table Asia Pacific Gene Therapy Revenue by Countries (2019-2030)
Table Asia Pacific Gene Therapy Revenue Market Share by Countries (2019-2030)
Figure China Gene Therapy Revenue and Growth (2019-2030)
Figure Japan Gene Therapy Revenue and Growth (2019-2030)
Figure Korea Gene Therapy Revenue and Growth (2019-2030)
Figure India Gene Therapy Revenue and Growth (2019-2030)
Figure Southeast Asia Gene Therapy Revenue and Growth (2019-2030)
Figure Australia Gene Therapy Revenue and Growth (2019-2030)
Table SWOT Analysis
Table South America Gene Therapy Revenue by Type (2019-2030)
Table South America Gene Therapy Revenue by Application (2019-2030)
Table South America Gene Therapy Revenue by Countries (2019-2030)
Table South America Gene Therapy Revenue Market Share by Countries (2019-2030)
Figure Brazil Gene Therapy Revenue and Growth (2019-2030)
Figure Argentina Gene Therapy Revenue and Growth (2019-2030)
Table SWOT Analysis
Table Middle East & Africa Gene Therapy Revenue by Type (2019-2030)
Table Middle East & Africa Gene Therapy Revenue by Application (2019-2030)
Table Middle East & Africa Gene Therapy Revenue by Countries (2019-2030)
Table Middle East & Africa Gene Therapy Revenue Market Share by Countries (2019-2030)
Figure Turkey Gene Therapy Revenue and Growth (2019-2030)
Figure Egypt Gene Therapy Revenue and Growth (2019-2030)
Figure Saudi Arabia Gene Therapy Revenue and Growth (2019-2030)
Figure UAE Gene Therapy Revenue and Growth (2019-2030)
Figure South Africa Gene Therapy Revenue and Growth (2019-2030)
Table SWOT Analysis
Figure Proportion of Business Cost Structure
Table Labor Cost Analysis
Table Operating Expenses Analysis
Figure Gene Therapy Industrial Chain Analysis
Table Research Process
Figure Bottom-up and Top-down Approaches for This Report